Related Experiment Video
Updated: Jul 21, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
How do i participate in T-cell immunotherapy?
Megan M Suhoski Davis1, David H McKenna2, Philip J Norris3,4
1Department of Pathology and Laboratory Medicine and the Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
Transfusion
|April 6, 2017
Summary
Blood banks can support T-cell therapies by collecting materials and distributing products. Deeper involvement in manufacturing T-cell therapeutics requires significant investment in facilities and expertise.
Area of Science:
- Immunology
- Cellular Therapy
Background:
- T cells are crucial for adaptive immunity and have advanced therapeutic applications.
- T-cell therapies show promise for treating cancers, infections, and transplant-related conditions.
Purpose of the Study:
- To define the evolving role of blood banks in the T-cell therapeutics supply chain.
- To explore the potential for blood banks to contribute to T-cell therapy manufacturing and distribution.
Main Methods:
- Analysis of the regulatory framework and operational capabilities of blood banks.
- Identification of infrastructure and process requirements for T-cell therapy production.
- Evaluation of the benefits and investment needs for blood bank involvement.
Main Results:
- Blood banks are well-positioned for raw material collection and finished product distribution.
- Expanded roles in manufacturing necessitate substantial investment in facilities and specialized expertise.
- Key requirements include clean room facilities, cell expansion equipment, SOPs, and quality assurance programs.
Conclusions:
- Blood banks can play a vital role in T-cell therapy logistics.
- Increased manufacturing involvement requires careful consideration of capital and expertise investments.
- Strategic engagement can offer growth opportunities for blood banks in novel therapies.
More Related Videos
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.